Drug intelligence / Profile preview

ethyl nitrite

Development stage
Phase 1
Modality
Small Molecules
Administration
Oral, Inhalation
01

Overview

Ethyl nitrite is a small molecule alkyl nitrite (chemical formula C2H5NO2) that has historically been used as an ingredient in traditional remedies for colds and flu—most notably in the South African preparation "Witdulsies" and in the US as "sweet spirit of nitre"[3][8]. It acts primarily as a vasodilator through the release of nitric oxide (NO), which relaxes vascular smooth muscle[6]. Ethyl nitrite is rapidly absorbed due to its high volatility and can cross cell membranes easily. Its main toxic effect is methemoglobinemia—a potentially fatal condition where hemoglobin is oxidized such that it cannot carry oxygen effectively[3][6]. The compound participates in the nitrate–nitrite–nitric oxide pathway in mammals. Due to safety concerns including risk of severe or fatal methemoglobinemia, over-the-counter sales have been banned by regulatory agencies such as the FDA since 1980[3]. Ethyl nitrite has no current approved pharmaceutical indications but may still be found in some traditional or experimental preparations.

Other names
ethyl alcohol nitritenitrous acid ethyl esternitrethylsweet spirit of nitresweet nitrite
02

Targets

sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on ethyl nitrite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethyl nitrite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call